FLT3 agonist antibody (Northern Biologics)

N/A

Report date: 2025/03/20 14:53:12

Base Information

Drug NameFLT3 agonist antibody (Northern Biologics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 stimulants
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthern Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesNorthern Biologics Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A